StockWatch
·

BioRestorative Therapies, Inc.

Ticker: 1505497

values in millions

Revenue & Profit Trend

in millions
RevenueExpenditureNet Profit
-6.87-2.461.956.36Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q1 FY2026

Margin Trend

percentage
OPM %NPM %
-102.00-100.67-99.33-98.00Q3 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q1 FY2026
PeriodQ1 FY2026Q3 FY2025Q2 FY2025Q1 FY2025Q3 FY2024Q2 FY2024Q1 FY2024Q3 FY2023
INCOME
Revenue0.02+100.0%0.01-96.7%0.30+900.0%0.03-87.0%0.23+155.6%0.09+125.0%0.04+33.3%0.03
Total Income0.02+100.0%0.01-96.7%0.30+900.0%0.03-87.0%0.23+155.6%0.09+125.0%0.04+33.3%0.03
EXPENSES
Expenditure3.41-8.3%3.72+3.0%3.61-25.3%4.83+91.7%2.52-1.6%2.56-38.2%4.14+31.8%3.14
PROFIT
Net Profit-2.15+29.3%-3.04-14.3%-2.66+50.2%-5.34-389.9%-1.09+73.0%-4.03-81.5%-2.22+24.2%-2.93
KEY METRICS
OPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
NPM %-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%-100.00%
EPS-0.12+63.6%-0.33-10.0%-0.30+53.1%-0.64-392.3%-0.13+74.0%-0.50-51.5%-0.33+48.4%-0.64

Corporate Events

Board MeetingBRTX
2026
12Jun

Board Meeting

Revolving Loan Agreement entered, leading to the resignation…

SEC Filing
Board MeetingBRTX
2026
10Jun

Board Meeting

Employment Agreement for Francisco Silva, VP, Research and D…

SEC Filing
Board MeetingBRTX
2026
26May

Board Meeting

New employment agreements for President/CEO/Chairman and CFO…

SEC Filing
Board MeetingBRTX
2026
1May

Board Meeting

Compensation Committee approved cash bonuses for executive o…

SEC Filing